UiPath Inc. (PATH) Key Metrics
PATH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $6.70B
- Enterprise value
- $5.59B
- P/E (TTM)
- 19.2
- Forward P/E
- 16.7
- PEG ratio
- 0.48
- Price / sales
- 3.9 10-yr median 8.0
- Price / book
- 3.5 10-yr median 4.4
- EV / EBITDA
- 31.2
- Dividend yield
- —
- Beta
- 1.01
PATH key metrics, FY2019–FY2026
Fiscal year ended January 31, 2026 · U.S. dollarsPATH valuation Price multiples at each fiscal year-end price.
PATH returns How much profit the business earns on the capital it uses.
PATH per-share figures Results divided by the shares outstanding at year-end.
PATH financial health Debt, liquidity and how easily interest is covered.
PATH efficiency & capital use Working capital cycle and where the cash goes.
PATH valuation history
PATH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
PATH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
PATH cash returned to shareholders
PATH price vs earnings per share
PATH key metrics
FY2019–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $6.86B | $7.96B | $12.96B | $8.42B | $19.77B | — | — | — |
| Enterprise value | $5.47B | $6.41B | $11.14B | $6.72B | $17.96B | — | — | — |
| P/E ratio | 24.3 | — | — | — | — | — | — | — |
| Price / sales | 4.3 | 5.6 | 9.9 | 8.0 | 22.2 | — | — | — |
| Price / book | 3.3 | 4.3 | 6.4 | 4.4 | 10.3 | — | — | — |
| Price / free cash flow | 19.5 | 26.1 | 44.4 | — | — | — | — | — |
| Price / operating cash flow | 18.5 | 24.8 | 43.3 | — | — | — | — | — |
| EV / sales | 3.4 | 4.5 | 8.5 | 6.4 | 20.1 | — | — | — |
| EV / EBITDA | 46.5 | — | — | — | — | — | — | — |
| EV / free cash flow | 15.5 | 21.0 | 38.2 | — | — | — | — | — |
| Earnings yield | 4.1% | −0.9% | −0.7% | −3.9% | −2.7% | — | — | — |
| Free cash flow yield | 5.1% | 3.8% | 2.3% | −0.4% | −0.3% | — | — | — |
| Shareholder yield (dividends + buybacks) | 4.8% | 4.9% | 0.8% | 0.0% | 0.1% | — | — | — |
| Share price at fiscal year-end | $12.59 | $14.22 | $22.98 | $15.36 | $36.53 | — | — | — |
| Per share | ||||||||
| Revenue per share | $2.96 | $2.55 | $2.32 | $1.93 | $1.65 | $1.17 | $0.65 | $0.29 |
| Earnings per share | $0.52 | −$0.13 | −$0.16 | −$0.60 | −$0.97 | −$0.18 | −$1.00 | −$0.50 |
| Operating cash flow per share | $0.68 | $0.57 | $0.53 | −$0.02 | −$0.10 | $0.06 | −$0.69 | — |
| Free cash flow per share | $0.65 | $0.55 | $0.52 | −$0.06 | −$0.13 | $0.05 | −$0.73 | — |
| Cash per share | $2.70 | $2.91 | $3.33 | $3.21 | $3.45 | $0.89 | $0.45 | — |
| Book value per share | $3.82 | $3.30 | $3.58 | $3.50 | $3.55 | $0.81 | $0.38 | — |
| Tangible book value per share | $3.56 | $3.13 | $3.39 | $3.30 | $3.42 | $0.73 | $0.31 | — |
| Capex per share | $0.03 | $0.03 | $0.01 | $0.04 | $0.02 | $0.01 | $0.04 | — |
| Debt per share | $0.15 | $0.14 | $0.12 | $0.12 | $0.09 | $0.04 | $0.05 | — |
| Shares outstanding | 544.9M | 559.9M | 563.9M | 548.0M | 541.2M | 519.2M | 519.2M | 519.2M |
| Change in shares outstanding | −2.7% | −0.7% | +2.9% | +1.3% | +4.3% | 0.0% | 0.0% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | 14.4% | −3.8% | −4.6% | −17.1% | −44.9% | −30.0% | −264.1% | — |
| Return on invested capital (ROIC) | 12.4% | −51.7% | −60.6% | −164.3% | −920.4% | — | — | — |
| Return on assets (ROA) | 9.3% | −2.5% | −3.2% | −12.4% | −30.6% | −13.4% | −102.3% | — |
| Return on tangible assets | 9.3% | −2.7% | −3.2% | −12.5% | −21.0% | −11.2% | −110.4% | — |
| Free cash flow margin | 21.9% | 21.4% | 22.3% | −3.2% | −7.6% | 4.3% | −113.2% | — |
| Income quality (OCF / net income) | 1.31 | — | — | — | — | — | — | — |
| Financial health | ||||||||
| Total debt | $81.2M | $77.8M | $67.1M | $63.4M | $51.4M | $20.1M | $26.3M | — |
| Cash & short-term investments | $1.47B | $1.63B | $1.88B | $1.76B | $1.87B | $460.5M | $232.4M | — |
| Net debt | −$1.39B | −$1.55B | −$1.81B | −$1.69B | −$1.81B | −$440.4M | −$206.1M | — |
| Debt / equity | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.13 | — |
| Debt / assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | — |
| Net debt / EBITDA | −11.83 | — | — | — | — | — | — | — |
| Current ratio | 2.48 | 2.93 | 3.63 | 3.74 | 4.32 | 2.01 | 1.68 | — |
| Quick ratio | 2.48 | 2.93 | 3.63 | 3.66 | 4.30 | 2.01 | 1.59 | — |
| Interest coverage | — | — | — | -12.5 | -141.1 | -7.0 | — | — |
| Working capital | $1.34B | $1.54B | $1.87B | $1.72B | $1.75B | $369.3M | $162.4M | — |
| Invested capital | $691.3M | $293.6M | $202.9M | $226.7M | $108.2M | −$22.2M | −$9.3M | — |
| Tangible asset value | $1.94B | $1.75B | $1.91B | $1.81B | $1.85B | $380.0M | $159.8M | — |
| Net current asset value | $1.15B | $1.32B | $1.64B | $1.53B | $1.63B | $286.2M | $89.7M | — |
| Graham number | $6.68 | — | — | — | — | — | — | — |
| Graham net-net per share | $1.49 | $1.82 | $2.37 | $2.38 | $2.72 | $0.34 | $0.04 | — |
| Capital allocation | ||||||||
| Share buybacks (net) | $329.1M | $390.8M | $102.6M | $1.5M | $10.5M | $0 | $128.8M | — |
| Dividends + buybacks / free cash flow | 93.5% | 127.8% | 35.2% | — | — | 0.0% | — | — |
| Capex / revenue | 1.2% | 1.0% | 0.6% | 2.2% | 1.5% | 0.5% | 6.2% | — |
| Capex / operating cash flow | 5.1% | 4.7% | 2.5% | — | — | 10.9% | — | — |
| Capex / depreciation | 1.12 | 0.87 | 0.32 | 1.27 | 0.89 | 0.16 | 1.34 | — |
| Stock-based compensation / revenue | 18.0% | 25.1% | 28.4% | 34.9% | 57.8% | 14.2% | 41.0% | — |
| R&D / revenue | 23.9% | 26.6% | 25.4% | 27.0% | 31.0% | 18.1% | 39.0% | 45.1% |
| SG&A / revenue | 55.7% | 67.5% | 72.2% | 88.9% | 106.2% | 89.2% | 197.2% | — |
| Efficiency | ||||||||
| Days sales outstanding | 127.2 | 136.1 | 135.4 | 135.1 | 113.4 | 100.9 | 128.5 | — |
| Days of inventory on hand | — | — | 46.5 | 60.8 | 10.9 | 58.5 | 129.7 | — |
| Days payables outstanding | 28.9 | 27.1 | 11.5 | 20.7 | 19.7 | 31.3 | 28.3 | — |
| Cash conversion cycle (days) | 98.4 | 109.0 | 170.4 | 175.2 | 104.7 | 128.1 | 229.8 | — |
| Receivables turnover | 2.87 | 2.68 | 2.69 | 2.70 | 3.22 | 3.62 | 2.84 | — |
| Payables turnover | 12.65 | 13.48 | 31.76 | 17.65 | 18.56 | 11.67 | 12.89 | — |
| Inventory turnover | — | — | 7.85 | 6.01 | 33.52 | 6.24 | 2.81 | — |
| Asset turnover | 0.53 | 0.49 | 0.46 | 0.40 | 0.52 | 0.88 | 0.66 | — |
| Average receivables | $561.5M | $533.0M | $485.4M | $391.9M | $277.3M | $168.0M | $118.3M | — |
| Average payables | $21.7M | $18.3M | $6.2M | $10.2M | $9.1M | $5.6M | $4.6M | — |
| Average inventory | — | — | $24.9M | $30.0M | $5.0M | $10.6M | $21.1M | — |
| Intangibles / total assets | 4.6% | 3.3% | 3.5% | 4.1% | 2.7% | 4.4% | 7.3% | — |
Computed from PATH's annual financial statements (latest annual report filed March 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
PATH valuation and financial ratios
At the end of fiscal 2026 (January 31, 2026), UiPath traded at 24.3 times earnings. Based on the latest twelve months, the trailing P/E is 19.2 and the forward P/E is 16.7. UiPath earned a return on equity of 14.4% and a return on invested capital of 12.4% in fiscal 2026. It ended the year with $81.2 million of debt and $1.5 billion in cash and short-term investments, a net cash position of $1.4 billion. It returned $329.1 million to shareholders: $0 in dividends and $329.1 million in share buybacks, 93% of free cash flow. The share count rose 5.0% from 519.2M to 544.9M over 7 years.
See the PATH income statement, the PATH chart for price history, or the PATH stock overview for the latest quote and news.
PATH key metrics FAQ
What is UiPath's P/E ratio?
UiPath's trailing P/E ratio is 19.2 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 16.7. At the end of fiscal 2026 it was 24.3.
What is UiPath's EV/EBITDA?
UiPath's enterprise value was 46.5 times EBITDA at the end of fiscal 2026 (enterprise value $5.5 billion, EBITDA $117.6 million); the current EV/EBITDA is 31.2.
What is UiPath's return on equity?
UiPath's return on equity (ROE) was 14.4% in fiscal 2026: net income of $282.3 million on average shareholders' equity of $2.0 billion.
What is UiPath's ROIC?
UiPath's return on invested capital was 12.4% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does UiPath have?
UiPath had total debt of $81.2 million at the end of fiscal 2026, a debt-to-equity ratio of 0.04 and more cash than debt.
Does UiPath buy back its shares?
Yes. UiPath spent $329.1 million on net share repurchases in fiscal 2026 Shares outstanding changed −2.7% over the year, to 544.9M..
What is UiPath's free cash flow yield?
UiPath generated $352.2 million of free cash flow in fiscal 2026, a free cash flow yield of 5.1% on its market value at year-end ($6.9 billion).
What is UiPath's current ratio?
UiPath's current ratio was 2.48 at the end of fiscal 2026: current assets were 2.48 times current liabilities.